BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 892352)

  • 1. Complications of diuresis in the alcoholic patient with ascites: a controlled trial.
    Gregory PB; Broekelschen PH; Hill MD; Lipton AB; Knauer CM; Egger M; Miller R
    Gastroenterology; 1977 Sep; 73(3):534-8. PubMed ID: 892352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatorenal syndrome: study of clinical characteristics in a large series.
    Bern MM
    South Med J; 1973 Jul; 66(7):775-8. PubMed ID: 4543096
    [No Abstract]   [Full Text] [Related]  

  • 3. Diuresis of ascites: fraught with or free from hazard.
    Conn HO
    Gastroenterology; 1977 Sep; 73(3):619-21. PubMed ID: 892360
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of bumetanide in the treatment of ascites due to liver disease.
    Moult PJ; Lunzer MR; Trash DB; Sherlock S
    Gut; 1974 Dec; 15(12):988-92. PubMed ID: 4448415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT; Shear L
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Diuretic-resistant' ascites. Observations on pathogenesis.
    Rector WG
    Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term course of corticosteroids in the treatment of resistant ascites complicating schistosomal liver disease.
    el-Zayadi A; Mohran Z; Hasseeb N; Nagy N; Dabbous H
    Am J Gastroenterol; 1991 Jan; 86(1):53-6. PubMed ID: 1986555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
    Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretics in malignant effusions and edemas of generalized cancer.
    Razis DV; Athanasiou A; Dadiotis L
    J Med; 1976; 7(6):449-61. PubMed ID: 1070516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
    Inoue J; Mori Y; Kawamura T
    Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
    [No Abstract]   [Full Text] [Related]  

  • 15. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
    Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
    J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined ascitic-fluid and furosemide infusion in the management of ascites.
    Eknoyan G; Martinez-Maldonado M; Yium JJ; Suki WN
    N Engl J Med; 1970 Mar; 282(13):713-7. PubMed ID: 5416204
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches to the treatment of edema and ascites: the use of diuretics.
    Somberg JC; Molnar J
    Am J Ther; 2009; 16(1):98-101. PubMed ID: 19142158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of ascites in cirrhosis of the liver].
    Del Solar V; Lobo G; Varela N; Lehmann C
    Rev Med Chil; 1965 Sep; 93(9):549-56. PubMed ID: 5888085
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites.
    Campra JL; Reynolds TB
    Am J Dig Dis; 1978 Nov; 23(11):1025-30. PubMed ID: 31086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.